Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:N Engl J Med
Autores principales: Walsh, Edward E., Frenck, Robert W., Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J., Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R., Jansen, Kathrin U., Şahin, Uğur, Gruber, William C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://ncbi.nlm.nih.gov/pubmed/33053279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2027906
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares